Hepatitis A Titer Test Panel
This Hepatitis A titer blood test panel checks HAV antibodies and related hepatitis markers to clarify immunity vs exposure and guide next steps.
This panel bundles multiple biomarker tests in one order—your report explains how results fit together.
This is a lab panel, meaning you get multiple related results back together—not a single number. A Hepatitis A titer is mainly about whether you have protective antibodies (immunity), but the most useful interpretation often comes from reading the HAV results alongside other hepatitis markers and liver-context tests when they’re included.
Do I need this panel?
You might consider the Hepatitis A Titer Test Panel if you are trying to confirm whether you’re immune to hepatitis A (HAV)—for example after vaccination, before travel, before certain jobs or school programs, or before starting medications that can affect your immune system.
This panel can also be helpful when you’re sorting through confusing hepatitis bloodwork (“IgM vs IgG,” “reactive vs non-reactive”) or when mild liver enzyme elevations (like ALT) have you wondering whether a recent viral infection could be part of the story.
If you have inflammatory bowel disease (IBD) or another condition where you may use immunosuppressive therapy, knowing your hepatitis A immunity status can help you and your clinician plan vaccination timing and reduce avoidable risk.
This panel supports clinician-directed care and follow-up. It is not meant to diagnose or treat on your own—especially if you have symptoms of acute hepatitis (jaundice/yellowing of skin or eyes, dark urine, pale stools, significant fatigue, nausea, right upper abdominal pain) or a known exposure.
Hepatitis serology is typically measured by immunoassay; result flags and reference ranges can vary by lab, so interpretation should focus on the pattern across markers rather than a single cutoff.
Lab testing
Order the Hepatitis A Titer Test Panel
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this panel with Vitals Vault
Vitals Vault makes it straightforward to order a hepatitis-focused lab panel when you want clarity on immunity, prior exposure, or whether a result needs follow-up. You can use this panel as a baseline before travel, before starting immune-modifying medications, or when you’re trying to make sense of liver-related lab changes.
After you receive your results, you can review the full pattern across the panel (not just one marker) and decide what to do next—whether that’s confirming vaccination status, discussing repeat testing timing, or adding companion labs that better explain liver enzyme changes.
If you want help prioritizing next steps based on your symptoms, medications, and risk factors, PocketMD can help you translate the panel into a practical plan to discuss with your clinician.
- Order a single panel and receive a set of related hepatitis markers together
- Designed for pattern-based interpretation (immunity vs recent infection vs no evidence of exposure)
- Useful for pre-travel, pre-employment/school, and pre-immunosuppression planning
- PocketMD support to help you interpret multi-marker results in context
Key benefits of the Hepatitis A Titer Test Panel
- Confirms whether you have protective hepatitis A antibodies (immunity), often after vaccination or past infection.
- Helps distinguish immunity from a possible recent/acute hepatitis A infection when IgM is included and interpreted correctly.
- Reduces “hepatitis alphabet soup” by showing related hepatitis markers together so the pattern is easier to understand.
- Supports safer planning before travel, certain jobs/school requirements, and before starting immune-modifying therapies.
- Provides context for mild liver enzyme elevations by pairing serology with liver-adjacent markers when included.
- Helps avoid unnecessary repeat vaccination when immunity is already present (based on your clinician’s guidance).
- Creates a clear baseline you can trend over time if your risk changes or if follow-up testing is recommended.
What is the Hepatitis A Titer Test Panel?
The Hepatitis A Titer Test Panel is a bundled set of blood tests that look for antibodies to hepatitis A virus (HAV) and, in many versions of the panel, related hepatitis markers that help you interpret what a positive or negative result actually means.
A “titer” in everyday use usually means an antibody result that indicates whether your immune system recognizes a specific virus. For hepatitis A, the most common goal is to confirm immunity—typically reflected by hepatitis A total antibody or hepatitis A IgG (immunoglobulin G) being positive/reactive.
Because hepatitis results can be misread when viewed in isolation, a panel approach is often more useful than ordering a single test. For example, HAV IgM (immunoglobulin M) is associated with recent infection, while HAV total antibody or IgG is associated with past infection or vaccination. Additional hepatitis markers (like hepatitis B surface antigen or hepatitis C antibody) may be included to help rule in or rule out other common viral causes of liver inflammation.
Your results should be interpreted alongside your situation: vaccination history, recent travel, food/water exposure risk, household contacts, symptoms, and medications (especially immune-suppressing drugs).
Immunity vs infection: why the pattern matters
For hepatitis A, many people are testing for one simple question: “Am I immune?” A reactive total antibody or IgG often supports immunity. A reactive IgM raises concern for a recent infection, but false positives can happen, and timing matters. Seeing multiple markers together helps your clinician decide whether the result fits your symptoms and exposure timeline.
Why this comes up with liver enzyme changes
ALT and AST are enzymes that can rise when liver cells are inflamed or injured. Viral hepatitis is one possible cause, but so are medications, alcohol, fatty liver disease, intense exercise, and other infections. A hepatitis-focused panel can help you avoid guessing by checking for evidence of viral exposure while you and your clinician consider other causes.
Why this comes up with IBD and immune-modifying medications
If you use (or may soon use) immune-modifying therapy, your care team may want to confirm immunity to vaccine-preventable infections. Hepatitis A is preventable with vaccination, and confirming your antibody status can help you time vaccination appropriately and reduce risk—especially if travel or outbreaks are part of your life.
What do my panel results mean?
Pattern suggesting no evidence of hepatitis A immunity
A common “low” or negative pattern is hepatitis A total antibody (or IgG) reported as non-reactive/negative, often with IgM also negative. This typically suggests you do not have detectable HAV antibodies—meaning you may not be immune. If you are testing for travel, work/school requirements, or before immune-modifying therapy, this is often a prompt to discuss hepatitis A vaccination with your clinician. If other hepatitis markers in the panel are also negative, that can be reassuring that there is no lab evidence of hepatitis B or C exposure at the time of testing, but it does not replace clinical evaluation if you have symptoms.
Pattern consistent with immunity (most common goal of a titer)
An “optimal” pattern for most people ordering a hepatitis A titer is a reactive/positive hepatitis A total antibody or IgG with a negative IgM. This usually fits immunity from prior vaccination or past infection and generally does not suggest an active hepatitis A infection. If the panel includes other hepatitis markers, having them negative/non-reactive at the same time can help keep the focus on immunity rather than active viral hepatitis as an explanation for symptoms or liver enzyme changes.
Pattern that may suggest recent hepatitis A infection or a result needing confirmation
A “high” concern pattern is HAV IgM reported as reactive/positive—especially if you also have symptoms consistent with acute hepatitis or a known exposure. In many labs, IgM is treated as a marker of recent infection, but it is not perfect: false positives and confusing borderline results can occur, and timing relative to symptom onset matters. If IgM is positive, your next step is usually prompt clinician follow-up for confirmatory testing, public health guidance when appropriate, and evaluation of liver inflammation (often including ALT/AST, bilirubin, and INR depending on severity). If other hepatitis markers are positive in the panel (such as hepatitis B surface antigen or hepatitis C antibody), interpretation becomes more complex and should be handled as a combined pattern rather than a single “positive/negative” label.
Factors that influence hepatitis A titer panel results
Vaccination timing is a major factor: testing too soon after vaccination may not reflect peak antibody levels, while testing long after vaccination can still show immunity even if the numeric value changes. Immune suppression (from medications or certain conditions) can blunt antibody responses and make results harder to interpret. Recent infections, autoimmune conditions, and lab-specific assay characteristics can contribute to borderline or unexpected IgM results. Finally, your pre-test probability matters: a positive IgM in someone with no symptoms and no exposure risk may be more likely to be a false positive than the same result in someone with compatible symptoms after a known exposure.
What’s included in this panel
- Hepatitis A Ab, Total
- Hepatitis A IgM
Frequently Asked Questions
Do I need to fast for the Hepatitis A Titer Test Panel?
Fasting is usually not required for hepatitis antibody testing. If your version of the panel includes additional metabolic markers ordered at the same time (outside this panel), fasting rules may change. Follow the instructions provided with your order, and ask your clinician if you are unsure.
What result shows I’m immune to hepatitis A?
In most lab reports, immunity is suggested when hepatitis A total antibody or hepatitis A IgG is reactive/positive, especially when hepatitis A IgM is negative. Your clinician may interpret this as immunity from vaccination or past infection.
If my hepatitis A IgM is positive, does that mean I have acute hepatitis A?
A positive/reactive HAV IgM can indicate a recent infection, but it is not a stand-alone diagnosis. False positives and borderline results can occur, and the timing of testing matters. If IgM is positive—especially with symptoms—seek prompt clinician follow-up for confirmation and liver inflammation assessment.
Why order a panel instead of just a single hepatitis A antibody test?
A panel helps you interpret the “why” behind a result. For example, IgG/total antibody helps answer immunity, while IgM helps evaluate possible recent infection. If other hepatitis markers are included, they can help rule in or rule out hepatitis B or C as alternative explanations for liver enzyme changes or symptoms.
Can I have normal liver enzymes and still have hepatitis A antibodies?
Yes. Many people who are immune from vaccination have normal ALT/AST and still have reactive total antibody or IgG. Antibodies reflect immune memory, not necessarily current liver inflammation.
I have IBD and take immune-modifying medication. How should I use this panel?
This panel can help document whether you have hepatitis A immunity before or during immune-modifying therapy. If you are not immune, your clinician can advise on vaccination timing and whether any additional hepatitis testing is needed based on your medication plan and risk factors.
How soon after a hepatitis A vaccine should I check a titer?
Antibody development takes time, and the best timing depends on the vaccine schedule, your immune status, and why you are testing (travel deadlines vs documentation). If you are immunosuppressed or have a tight timeline, ask your clinician for personalized timing guidance.